Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pancreatic A cell | 4 studies | 35% ± 7% | |
| type B pancreatic cell | 4 studies | 34% ± 6% | |
| glomerular endothelial cell | 4 studies | 34% ± 6% | |
| endothelial cell | 3 studies | 27% ± 11% | |
| retinal ganglion cell | 3 studies | 71% ± 15% | |
| retina horizontal cell | 3 studies | 32% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pancreas | 4 studies | 28% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 2457.09 | 2628 / 2642 | 90% | 37.79 | 633 / 705 |
| thymus | 100% | 968.98 | 651 / 653 | 89% | 47.81 | 540 / 605 |
| pancreas | 96% | 481.86 | 316 / 328 | 86% | 22.81 | 153 / 178 |
| kidney | 99% | 603.63 | 88 / 89 | 81% | 20.69 | 728 / 901 |
| ovary | 81% | 378.93 | 145 / 180 | 62% | 12.02 | 266 / 430 |
| lung | 83% | 446.87 | 482 / 578 | 58% | 10.13 | 669 / 1155 |
| prostate | 61% | 197.25 | 149 / 245 | 77% | 16.80 | 386 / 502 |
| adrenal gland | 33% | 123.42 | 85 / 258 | 78% | 54.96 | 179 / 230 |
| breast | 40% | 113.00 | 183 / 459 | 66% | 9.80 | 740 / 1118 |
| stomach | 51% | 149.33 | 182 / 359 | 39% | 7.32 | 111 / 286 |
| uterus | 51% | 191.43 | 86 / 170 | 29% | 10.48 | 131 / 459 |
| blood vessel | 66% | 248.94 | 885 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 15% | 36.68 | 143 / 966 | 43% | 7.30 | 226 / 527 |
| eye | 0% | 0 | 0 / 0 | 48% | 8.68 | 38 / 80 |
| liver | 9% | 21.85 | 20 / 226 | 36% | 4.89 | 146 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 3.84 | 12 / 29 |
| esophagus | 7% | 17.02 | 101 / 1445 | 33% | 3.89 | 60 / 183 |
| bladder | 0% | 0 | 0 / 21 | 31% | 5.28 | 158 / 504 |
| spleen | 30% | 75.80 | 72 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 29% | 2.80 | 13 / 45 |
| skin | 7% | 15.44 | 121 / 1809 | 13% | 1.88 | 63 / 472 |
| heart | 14% | 35.73 | 120 / 861 | 0% | 0 | 0 / 0 |
| adipose | 10% | 24.89 | 119 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 3% | 7.86 | 29 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007165 | Biological process | signal transduction |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | BEX5 |
| Protein name | Protein BEX5 (Brain-expressed X-linked protein 5) (NGFRAP1-like protein 1) (Nerve growth factor receptor-associated protein 2) |
| Synonyms | NADE2 NGFRAP1L1 |
| Description | |
| Accessions | Q5H9J7 ENST00000708878.1 ENST00000543160.5 ENST00000333643.4 ENST00000708879.1 |